Let’s explore “Total cholesterol — lab reference”

<10 severe deficiency; 10-19 mild-moderate deficiency. Toxicity assessment requires clinical context.

Morning collection preferred for men. Method and age matter; confirm unexpected low values.

No single normal cutoff fits every patient. Ask your clinician to use age, baseline, trend, prostate size, risk factors, and shared decision-making.

Often used when total PSA is in an indeterminate zone. Ask your clinician to use the performing-lab risk table.

Depends on total testosterone, SHBG, albumin, calculation, and assay.

150-199 borderline high; 200-499 high; ≥500 severe and pancreatitis-relevant.

90-99 above desirable; 100-119 borderline high; 120-139 high; ≥140 very high. Risk goals may be lower.

The test method matters. Ask your clinician to read this result with HDL and ApoB.

Approximate risk strata are sex-specific and assay-dependent.

≥75 increased; ≥125 commonly treated as a risk-enhancing level. Units are not directly interchangeable with mg/dL.

≥2 suggests higher cardiovascular risk; >10 may reflect acute inflammation and should generally be repeated when well.

Age, kidney function, obesity, rhythm, and clinical setting affect interpretation.